Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein

被引:10
|
作者
Hao, Meng [1 ,2 ,3 ]
Zhang, Guanying [3 ]
Zhang, Shengnan [4 ]
Chen, Zhengshan [5 ]
Chi, Xiangyang [3 ]
Dong, Yunzhu [3 ]
Fan, Pengfei [3 ]
Liu, Yujiao [3 ]
Chen, Yi [3 ]
Song, Xiaohong [3 ]
Liu, Shuling [3 ]
Yu, Changming [3 ]
Li, Jianmin [3 ]
Xia, Xianzhu [1 ,2 ,6 ]
机构
[1] Chinese Acad Med Sci, Comparat Med Ctr, Peking Union Med Coll, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100021, Peoples R China
[3] Beijing Inst Biotechnol, Beijing 100071, Peoples R China
[4] Northeast Forestry Univ, Coll Wildlife & Protected Areas, Harbin 150040, Peoples R China
[5] Tianjin Institue Envionmental & Operat Med, Key Lab Risk Assessment & Control Environm & Food, Tianjin 300050, Peoples R China
[6] Chinese Acad Agr Sci, Changchun Vet Res Inst, Changchun 130000, Peoples R China
来源
VIRUSES-BASEL | 2020年 / 12卷 / 03期
关键词
Rift Valley fever virus (RVFV); neutralizing antibody (NAb); Gn protein; critical residues; MONOCLONAL-ANTIBODIES; EPIDEMIC; VACCINE; IDENTIFICATION;
D O I
10.3390/v12030259
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Rift Valley fever virus (RVFV) is an arthropod-borne virus that can not only cause severe disease in domestic animals but also in humans. However, the licensed vaccines or available therapeutics for humans do not exist. Here, we report two Gn-specific neutralizing antibodies (NAbs), isolated from a rhesus monkey immunized with recombinant human adenoviruses type 4 expressing Rift Valley fever virus Gn and Gc protein (rHAdV4-GnGcopt). The two NAbs were both able to protect host cells from RVFV infection. The interactions between NAbs and Gn were then characterized to demonstrate that these two NAbs might preclude RVFV glycoprotein rearrangement, hindering the exposure of fusion loops in Gc to endosomal membranes after the virus invades the host cell. The target region for the two NAbs is located in the Gn domain III, implying that Gn is a desired target for developing vaccines and neutralizing antibodies against RVFV.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
    Wright, Daniel
    Allen, Elizabeth R.
    Clark, Madeleine H. A.
    Gitonga, John N.
    Karanja, Henry K.
    Hulswit, Ruben J. G.
    Taylor, Iona
    Biswas, Sumi
    Marshall, Jennifer
    Mwololo, Damaris
    Muriuki, John
    Bett, Bernard
    Bowden, Thomas A.
    Warimwe, George M.
    ISCIENCE, 2020, 23 (11)
  • [2] Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc
    Susanne Jäckel
    Martin Eiden
    Malte Dauber
    Anne Balkema-Buschmann
    Alejandro Brun
    Martin H. Groschup
    Archives of Virology, 2014, 159 : 535 - 546
  • [3] Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc
    Jaeckel, Susanne
    Eiden, Martin
    Dauber, Malte
    Balkema-Buschmann, Anne
    Brun, Alejandro
    Groschup, Martin H.
    ARCHIVES OF VIROLOGY, 2014, 159 (03) : 535 - 546
  • [4] Generation and Characterization of Monoclonal Antibodies Against Rift Valley Fever Virus Nucleoprotein
    Fafetine, J. M.
    Domingos, A.
    Antunes, S.
    Esteves, A.
    Paweska, J. T.
    Coetzer, J. A. W.
    Rutten, V. P. M. G.
    Neves, L.
    TRANSBOUNDARY AND EMERGING DISEASES, 2013, 60 : 24 - 30
  • [5] Antibodies against Rift Valley Fever Virus in Cattle, Mozambique
    Lagerqvist, Nina
    Moiane, Belisario
    Mapaco, Lourenco
    Fafetine, Jose
    Vene, Sirkka
    Falk, Kerstin I.
    EMERGING INFECTIOUS DISEASES, 2013, 19 (07) : 1177 - 1179
  • [6] Characterization of the Golgi retention motif of Rift Valley fever virus GN glycoprotein
    Gerrard, SR
    Nichol, ST
    JOURNAL OF VIROLOGY, 2002, 76 (23) : 12200 - 12210
  • [7] Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization
    Martin-Folgar, Raquel
    Lorenzo, Gema
    Boshra, Hani
    Iglesias, Javier
    Mateos, Francisco
    Borrego, Belen
    Brun, Alejandro
    MABS, 2010, 2 (03) : 275 - 284
  • [8] Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife
    Evans, A.
    Gakuya, F.
    Paweska, J. T.
    Rostal, M.
    Akoolo, L.
    Van Vuren, P. J.
    Manyibe, T.
    Macharia, J. M.
    Ksiazek, T. G.
    Feikin, D. R.
    Breiman, R. F.
    Njenga, M. Kariuki
    EPIDEMIOLOGY AND INFECTION, 2008, 136 (09): : 1261 - 1269
  • [9] Characterization of RNA aptamers directed against the nucleocapsid protein of Rift Valley fever virus
    Ellenbecker, Mary
    Sears, Leila
    Li, Ping
    Lanchy, Jean-Marc
    Lodmell, J. Stephen
    ANTIVIRAL RESEARCH, 2012, 93 (03) : 330 - 339
  • [10] Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production
    Bracci, Nicole
    de la Fuente, Cynthia
    Saleem, Sahar
    Pinkham, Chelsea
    Narayanan, Aarthi
    Garcia-Sastre, Adolfo
    Balaraman, Velmurugan
    Richt, Juergen A.
    Wilson, William
    Kehn-Hall, Kylene
    VIROLOGY, 2022, 567 : 65 - 76